Joseph Reilly's most recent trade in Minerva Neurosciences Inc was a trade of 8,750 Restricted Stock Unit done . Disclosure was reported to the exchange on Dec. 14, 2020.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Minerva Neurosciences Inc | Joseph Reilly | SVP & Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2020 | 8,750 | 0 | - | - | Restricted Stock Unit | |
Minerva Neurosciences Inc | Joseph Reilly | SVP & Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2020 | 8,750 | 34,975 (0%) | 0% | - | Common Stock | |
Minerva Neurosciences Inc | Joseph Reilly | SVP & Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 2.64 per share. | 14 Dec 2020 | 3,228 | 31,747 (0%) | 0% | 2.6 | 8,522 | Common Stock |
Provident Bancorp Inc | Joseph B. Reilly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Nov 2020 | 25,500 | 25,500 | - | - | Stock Options | |
Provident Bancorp Inc | Joseph B. Reilly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Nov 2020 | 10,210 | 18,072 (0%) | 0% | 0 | Common Stock | |
Minerva Neurosciences Inc | Joseph Reilly | SVP & Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2020 | 85,000 | 85,000 | - | - | Employee Stock Option (right to buy) | |
Minerva Neurosciences Inc | Joseph Reilly | SVP & Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2020 | 153,531 | 153,531 | - | - | Employee Stock Option (right to buy) |